Exact Mass: 315.0695868

Exact Mass Matches: 315.0695868

Found 71 metabolites which its exact mass value is equals to given mass value 315.0695868, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Oxfendazole

Oxfendazole

C15H13N3O3S (315.06775880000004)


D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C250 - Antihelminthic Agent CONFIDENCE standard compound; INTERNAL_ID 438; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3672; ORIGINAL_PRECURSOR_SCAN_NO 3670 CONFIDENCE standard compound; INTERNAL_ID 438; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3663; ORIGINAL_PRECURSOR_SCAN_NO 3660 CONFIDENCE standard compound; INTERNAL_ID 438; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3677; ORIGINAL_PRECURSOR_SCAN_NO 3673 CONFIDENCE standard compound; INTERNAL_ID 438; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3666; ORIGINAL_PRECURSOR_SCAN_NO 3662 CONFIDENCE standard compound; INTERNAL_ID 438; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3739; ORIGINAL_PRECURSOR_SCAN_NO 3736 CONFIDENCE standard compound; INTERNAL_ID 438; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3676; ORIGINAL_PRECURSOR_SCAN_NO 3674 CONFIDENCE standard compound; INTERNAL_ID 438; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7569; ORIGINAL_PRECURSOR_SCAN_NO 7565 CONFIDENCE standard compound; INTERNAL_ID 438; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7593; ORIGINAL_PRECURSOR_SCAN_NO 7591 CONFIDENCE standard compound; INTERNAL_ID 438; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7621; ORIGINAL_PRECURSOR_SCAN_NO 7619 CONFIDENCE standard compound; INTERNAL_ID 438; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7615; ORIGINAL_PRECURSOR_SCAN_NO 7613 CONFIDENCE standard compound; INTERNAL_ID 438; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7596; ORIGINAL_PRECURSOR_SCAN_NO 7593 CONFIDENCE standard compound; INTERNAL_ID 438; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7629; ORIGINAL_PRECURSOR_SCAN_NO 7627 CONFIDENCE standard compound; INTERNAL_ID 1165 CONFIDENCE standard compound; INTERNAL_ID 1065

   
   

Oxfendazole

(5-(Phenylsulphinyl)-1H-benzimidazol-2-yl)carbamic acid methyl ester

C15H13N3O3S (315.06775880000004)


D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C250 - Antihelminthic Agent Anthelmintic, used in cattle, sheep and horse

   

Avenanthramide C

2-{[(2E)-3-(3,4-dihydroxyphenyl)-1-hydroxyprop-2-en-1-ylidene]amino}-5-hydroxybenzoate

C16H13NO6 (315.0742838)


Avenanthramide c is a member of the class of compounds known as avenanthramides. Avenanthramides are a group of phenolic alkaloids consisting of conjugate of three phenylpropanoids (ferulic, caffeic, or p-coumaric acid) and anthranilic acid. Avenanthramide c is practically insoluble (in water) and a weakly acidic compound (based on its pKa). Avenanthramide c can be found in cereals and cereal products, which makes avenanthramide c a potential biomarker for the consumption of this food product. N-(3,4-Dihydroxycinnamoyl)-2-amino-5-hydroxybenzoic acid is found in cereals and cereal products. N-(3,4-Dihydroxycinnamoyl)-2-amino-5-hydroxybenzoic acid is isolated from oats (Avena sativa).

   

4-Hydroxyfenbendazole

methyl N-{5-[(4-hydroxyphenyl)sulfanyl]-3H-1,3-benzodiazol-2-yl}carbamate

C15H13N3O3S (315.06775880000004)


   

N-(3-Chlorophenyl)-6,7-dimethoxyquinazolin-4-amine

N-(3-Chlorophenyl)-6,7-dimethoxyquinazolin-4-amine

C16H14ClN3O2 (315.0774494)


C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor D000970 - Antineoplastic Agents > D020032 - Tyrphostins D004791 - Enzyme Inhibitors

   

Fotemustina

diethyl {1-[N-(2-chloroethyl)-N-nitroso-(C-hydroxycarbonimidoyl)amino]ethyl}phosphonate

C9H19ClN3O5P (315.0750804)


   

N-(3',4'-Dihydroxycinnamoyl)-5-hydroxyanthranilic acid

2-{[3-(3,4-dihydroxyphenyl)-1-hydroxyprop-2-en-1-ylidene]amino}-5-hydroxybenzoate

C16H13NO6 (315.0742838)


   

Phosphonate analog

{5-[(6-hydroxy-2-imino-3,9-dihydro-2H-purin-9-yl)methyl]oxolan-2-yl}phosphonate

C10H14N5O5P (315.07325240000006)


   

TrkA Inhibitor

4-{[(2-hydroxy-1H-indol-3-yl)methylidene]amino}benzene-1-sulphonamide

C15H13N3O3S (315.06775880000004)


   

Avenanthramide K

2-{[(2E)-3-(3,4-dihydroxyphenyl)-1-hydroxyprop-2-en-1-ylidene]amino}-4-hydroxybenzoate

C16H13NO6 (315.0742838)


Avenanthramide k is a member of the class of compounds known as avenanthramides. Avenanthramides are a group of phenolic alkaloids consisting of conjugate of three phenylpropanoids (ferulic, caffeic, or p-coumaric acid) and anthranilic acid. Avenanthramide k is practically insoluble (in water) and a weakly acidic compound (based on its pKa). Avenanthramide k can be found in oat, which makes avenanthramide k a potential biomarker for the consumption of this food product.

   
   

AG-1478

N-(3-Chlorophenyl)-6,7-dimethoxyquinazolin-4-amine

C16H14ClN3O2 (315.0774494)


C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor D000970 - Antineoplastic Agents > D020032 - Tyrphostins D004791 - Enzyme Inhibitors

   

Nicosulfuron-TP UCSN

Nicosulfuron-TP UCSN

C10H13N5O5S (315.0637368000001)


CONFIDENCE standard compound; UCHEM_ID 4212

   
   

p-[N-Propyl-N-(2-carboxyethyl)sulfamoyl]benzoic acid

p-[N-Propyl-N-(2-carboxyethyl)sulfamoyl]benzoic acid

C13H17NO6S (315.07765420000004)


   

S-NEPC

4-nitrophenyl-2S,3S-epoxy-3 phenylpropyl carbonate

C16H13NO6 (315.0742838)


   

Avenanthramide C

2-[(2E)-3-(3,4-dihydroxyphenyl)prop-2-enamido]-5-hydroxybenzoic acid

C16H13NO6 (315.0742838)


   

Sulfamide,N-(6-hydroxy-4,5,7-trimethyl-2-benzothiazolyl)-N,N-dimethyl-

Sulfamide,N-(6-hydroxy-4,5,7-trimethyl-2-benzothiazolyl)-N,N-dimethyl-

C12H17N3O3S2 (315.07112920000003)


   

3-[[2-(4-carboxyphenoxy)acetyl]amino]benzoic acid

3-[[2-(4-carboxyphenoxy)acetyl]amino]benzoic acid

C16H13NO6 (315.0742838)


   

3-[[2-(1,3-benzodioxol-5-yloxy)acetyl]amino]benzoic acid

3-[[2-(1,3-benzodioxol-5-yloxy)acetyl]amino]benzoic acid

C16H13NO6 (315.0742838)


   

1-ETHANONE, 2-CHLORO-1-[2,5-DIMETHYL-1-[3-(TRIFLUOROMETHYL)PHENYL]-1H-PYRROL-3-YL]-

1-ETHANONE, 2-CHLORO-1-[2,5-DIMETHYL-1-[3-(TRIFLUOROMETHYL)PHENYL]-1H-PYRROL-3-YL]-

C15H13ClF3NO (315.0637714)


   

3-CHLORO-3-(CYCLOPROPYLCARBAMOYL)-[1,1-BIPHENYL]-4-CARBOXYLIC ACID

3-CHLORO-3-(CYCLOPROPYLCARBAMOYL)-[1,1-BIPHENYL]-4-CARBOXYLIC ACID

C17H14ClNO3 (315.06621640000003)


   

[4-(pyridin-3-ylmethyl)morpholin-2-yl]methanamine

[4-(pyridin-3-ylmethyl)morpholin-2-yl]methanamine

C11H20Cl3N3O (315.06718800000004)


   

Fotemustine

Fotemustine

C9H19ClN3O5P (315.0750804)


L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01A - Alkylating agents > L01AD - Nitrosoureas C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D000970 - Antineoplastic Agents

   

3-[2-(4-Chlorophenoxy)phenyl]-1,5-dihydro-4-hydroxy-1-methyl-2H-pyrrol-2-one

3-[2-(4-Chlorophenoxy)phenyl]-1,5-dihydro-4-hydroxy-1-methyl-2H-pyrrol-2-one

C17H14ClNO3 (315.06621640000003)


   

2-[4-(2-pyrimidinyl)-1-piperazinyl]ethanamine(SALTDATA: 3HCl)

2-[4-(2-pyrimidinyl)-1-piperazinyl]ethanamine(SALTDATA: 3HCl)

C10H20Cl3N5 (315.07842100000005)


   

ETHYL 2-(4-CHLOROPHENYL)-7-METHYLPYRAZOLO[1,5-A]PYRIMIDINE-6-CARBOXYLATE

ETHYL 2-(4-CHLOROPHENYL)-7-METHYLPYRAZOLO[1,5-A]PYRIMIDINE-6-CARBOXYLATE

C16H14ClN3O2 (315.0774494)


   

ethyl 4-chloro-5-methyl-7-phenylpyrrolo[2,3-d]pyrimidine-6-carboxylate

ethyl 4-chloro-5-methyl-7-phenylpyrrolo[2,3-d]pyrimidine-6-carboxylate

C16H14ClN3O2 (315.0774494)


   

2-CYANO-2-(3-ETHYL-4-OXO-5-((PHENYLAMINO)METHYLENE)THIAZOLIDIN-2-YLIDENE)ACETIC ACID

2-CYANO-2-(3-ETHYL-4-OXO-5-((PHENYLAMINO)METHYLENE)THIAZOLIDIN-2-YLIDENE)ACETIC ACID

C15H13N3O3S (315.06775880000004)


   

N-(p-Toluenesulfonyl)indole-3-boronic acid

N-(p-Toluenesulfonyl)indole-3-boronic acid

C15H14BNO4S (315.07365540000006)


   

5-METHYL-2-PHENYL-2,5-DIHYDRO-1H-PYRAZOL-3-YL 2-CHLORONICOTINATE

5-METHYL-2-PHENYL-2,5-DIHYDRO-1H-PYRAZOL-3-YL 2-CHLORONICOTINATE

C16H14ClN3O2 (315.0774494)


   

1-(benzenesulfonyl)indole-2-carbohydrazide

1-(benzenesulfonyl)indole-2-carbohydrazide

C15H13N3O3S (315.06775880000004)


   

4-Chloro-2-(piperazin-1-yl)-6-(trifluoromethyl)quinoline

4-Chloro-2-(piperazin-1-yl)-6-(trifluoromethyl)quinoline

C14H13ClF3N3 (315.0750044)


   

b-Alanine,N-(2-carboxyethyl)-N-[(4-methylphenyl)sulfonyl]-

b-Alanine,N-(2-carboxyethyl)-N-[(4-methylphenyl)sulfonyl]-

C13H17NO6S (315.07765420000004)


   

2-(2-CHLORO-ACETYLAMINO)-5,6,7,8-TETRAHYDRO-4H-CYCLOHEPTA[B]THIOPHENE-3-CARBOXYLIC ACID ETHYL ESTER

2-(2-CHLORO-ACETYLAMINO)-5,6,7,8-TETRAHYDRO-4H-CYCLOHEPTA[B]THIOPHENE-3-CARBOXYLIC ACID ETHYL ESTER

C14H18ClNO3S (315.0695868)


   

5-BENZYLOXY-2-NITROPHENYLPYRUVIC ACID

5-BENZYLOXY-2-NITROPHENYLPYRUVIC ACID

C16H13NO6 (315.0742838)


   
   

[4-(pyridin-2-ylmethyl)morpholin-2-yl]methanamine

[4-(pyridin-2-ylmethyl)morpholin-2-yl]methanamine

C11H20Cl3N3O (315.06718800000004)


   

{[4-Benzyl-5-(2-furyl)-4H-1,2,4-triazol-3-yl]sulfanyl}acetic acid

{[4-Benzyl-5-(2-furyl)-4H-1,2,4-triazol-3-yl]sulfanyl}acetic acid

C15H13N3O3S (315.06775880000004)


   

3-amino-4-(4-chloro-3,5-dimethylphenoxy)benzotrifluoride

3-amino-4-(4-chloro-3,5-dimethylphenoxy)benzotrifluoride

C15H13ClF3NO (315.0637714)


   

2-(2-CHLORO-ACETYLAMINO)-6-METHYL-4,5,6,7-TETRAHYDRO-BENZO[B]THIOPHENE-3-CARBOXYLIC ACID ETHYL ESTER

2-(2-CHLORO-ACETYLAMINO)-6-METHYL-4,5,6,7-TETRAHYDRO-BENZO[B]THIOPHENE-3-CARBOXYLIC ACID ETHYL ESTER

C14H18ClNO3S (315.0695868)


   

3-(5-chloro-2-phenoxyphenyl)-1-methylpyrrolidine-2,4-dione

3-(5-chloro-2-phenoxyphenyl)-1-methylpyrrolidine-2,4-dione

C17H14ClNO3 (315.06621640000003)


   

Carboxy-PTIO potassium salt

Carboxy-PTIO potassium salt

C14H16KN2O4 (315.0747096)


   

AZD-4635

AZD-4635

C15H11ClFN5 (315.0686968)


AZD4635 (HTL1071) is a potent, selective and orally active adenosine A2A receptor (A2AR) antagonist. AZD4635 binds to human A2AR with a Ki of 1.7 nM and shows >30-fold selectivity over other adenosine receptors[1].

   

N-((2-methyl-5-nitrophenyl)carbamothioyl)benzamide

N-((2-methyl-5-nitrophenyl)carbamothioyl)benzamide

C15H13N3O3S (315.06775880000004)


   

1-[(3,4-dimethoxyphenyl)sulfonyl]proline

1-[(3,4-dimethoxyphenyl)sulfonyl]proline

C13H17NO6S (315.07765420000004)


   

2-(3-chloro-2-oxo-1,3-dihydroindol-4-yl)ethyl benzoate

2-(3-chloro-2-oxo-1,3-dihydroindol-4-yl)ethyl benzoate

C17H14ClNO3 (315.06621640000003)


   
   

1-Methyl ethyl 2-chloro-5-[[[(1-methylethoxy)thiooxo]methyl]amino]-benzoate

1-Methyl ethyl 2-chloro-5-[[[(1-methylethoxy)thiooxo]methyl]amino]-benzoate

C14H18ClNO3S (315.0695868)


   

2,5-Dideoxy-adenosine 3-monophosphate

2,5-Dideoxy-adenosine 3-monophosphate

C10H14N5O5P (315.07325240000006)


   

9-phenyl-3,4a,5,6,7,8,8a,9-octahydro-2H-5,8-methanothiochromeno[2,3-d][1,3]thiazol-2-one

9-phenyl-3,4a,5,6,7,8,8a,9-octahydro-2H-5,8-methanothiochromeno[2,3-d][1,3]thiazol-2-one

C17H17NOS2 (315.0751512)


   

diethyl [(1S)-1-{[(2-chloroethyl)(nitroso)carbamoyl]amino}ethyl]phosphonate

diethyl [(1S)-1-{[(2-chloroethyl)(nitroso)carbamoyl]amino}ethyl]phosphonate

C9H19ClN3O5P (315.0750804)


D000970 - Antineoplastic Agents

   

(3r)-3-Ethyl-N-[(4-Methylphenyl)sulfonyl]-L-Aspartic Acid

(3r)-3-Ethyl-N-[(4-Methylphenyl)sulfonyl]-L-Aspartic Acid

C13H17NO6S (315.07765420000004)


   

2,5-dihydroxybenzoic acid 5-O-beta-D-glucoside

2,5-dihydroxybenzoic acid 5-O-beta-D-glucoside

C13H15O9- (315.071604)


   

5-Hydroxy-2-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybenzoate

5-Hydroxy-2-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybenzoate

C13H15O9- (315.071604)


   

N-(1H-benzimidazol-2-yl)-2-methylsulfonylbenzamide

N-(1H-benzimidazol-2-yl)-2-methylsulfonylbenzamide

C15H13N3O3S (315.06775880000004)


   

4-(4-chlorophenyl)-3-(2-phenylethyl)-1H-1,2,4-triazole-5-thione

4-(4-chlorophenyl)-3-(2-phenylethyl)-1H-1,2,4-triazole-5-thione

C16H14ClN3S (315.0596914)


   

N-[5-[(4-methoxyphenyl)methyl]-1,3,4-thiadiazol-2-yl]-2-furancarboxamide

N-[5-[(4-methoxyphenyl)methyl]-1,3,4-thiadiazol-2-yl]-2-furancarboxamide

C15H13N3O3S (315.06775880000004)


   
   

4-hydroxy-1-methyl-N-(5-methyl-1,3-thiazol-2-yl)-2-oxo-1,2-dihydro-3-quinolinecarboxamide

4-hydroxy-1-methyl-N-(5-methyl-1,3-thiazol-2-yl)-2-oxo-1,2-dihydro-3-quinolinecarboxamide

C15H13N3O3S (315.06775880000004)


   

2-Amino-3-[hydroxy-(2-hydroxy-3-propanoyloxypropoxy)phosphoryl]oxypropanoic acid

2-Amino-3-[hydroxy-(2-hydroxy-3-propanoyloxypropoxy)phosphoryl]oxypropanoic acid

C9H18NO9P (315.0719148)


   

hydroxyfenbendazole

hydroxyfenbendazole

C15H13N3O3S (315.06775880000004)


A member of the class of benzimidazoles that is fenbendazole in which the hydrogen at position 4 on the phenyl ring has been replaced by a hydroxy group.

   
   

1-[(2r,3r,4s,5r)-5-(1-amino-2-oxoethyl)-3,4-dihydroxyoxolan-2-yl]-4-hydroxy-2-oxopyrimidine-5-carboxylic acid

1-[(2r,3r,4s,5r)-5-(1-amino-2-oxoethyl)-3,4-dihydroxyoxolan-2-yl]-4-hydroxy-2-oxopyrimidine-5-carboxylic acid

C11H13N3O8 (315.0702618)


   

2-{[(2e)-3-(3,4-dihydroxyphenyl)-1-hydroxyprop-2-en-1-ylidene]amino}-5-hydroxybenzoic acid

2-{[(2e)-3-(3,4-dihydroxyphenyl)-1-hydroxyprop-2-en-1-ylidene]amino}-5-hydroxybenzoic acid

C16H13NO6 (315.0742838)


   

4-bromo-n-(5-carbamimidamidopentyl)-1h-pyrrole-2-carboxamide

4-bromo-n-(5-carbamimidamidopentyl)-1h-pyrrole-2-carboxamide

C11H18BrN5O (315.0694638)


   

2-{[(2e)-3-(3,4-dihydroxyphenyl)-1-hydroxyprop-2-en-1-ylidene]amino}-4-hydroxybenzoic acid

2-{[(2e)-3-(3,4-dihydroxyphenyl)-1-hydroxyprop-2-en-1-ylidene]amino}-4-hydroxybenzoic acid

C16H13NO6 (315.0742838)